---
figid: PMC8975771__40262_2021_1077_Fig1_HTML
figtitle: 'Therapeutic Drug Monitoring of Endoxifen for Tamoxifen Precision Dosing:
  Feasible in Patients with Hormone-Sensitive Breast Cancer'
organisms:
- NA
organisms_ner:
- NA
pmcid: PMC8975771
filename: 40262_2021_1077_Fig1_HTML.jpg
figlink: /pmc/articles/PMC8975771/figure/Fig1/
number: F1
caption: Main metabolism pathway of tamoxifen into its most active metabolite, endoxifen.
  CYP cytochrome P450
papertitle: 'Therapeutic Drug Monitoring of Endoxifen for Tamoxifen Precision Dosing:
  Feasible in Patients with Hormone-Sensitive Breast Cancer.'
reftext: C. Louwrens Braal, et al. Clin Pharmacokinet. 2022;61(4):527-537.
year: '2022'
doi: 10.1007/s40262-021-01077-z
journal_title: Clinical Pharmacokinetics
journal_nlm_ta: Clin Pharmacokinet
publisher_name: Springer International Publishing
keywords: ''
automl_pathway: 0.5511652
figid_alias: PMC8975771__F1
figtype: Figure
redirect_from: /figures/PMC8975771__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8975771__40262_2021_1077_Fig1_HTML.html
  '@type': Dataset
  description: Main metabolism pathway of tamoxifen into its most active metabolite,
    endoxifen. CYP cytochrome P450
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - tamoxifen
  - Tamoxifen
  - Endoxifen
---
